These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Physiological focus on the erythropoietin-hepcidin-ferroportin axis. D'Anna MC, Roque ME. Can J Physiol Pharmacol; 2013 May; 91(5):338-45. PubMed ID: 23656253 [Abstract] [Full Text] [Related]
23. Non-mutagenic Suppression of Enterocyte Ferroportin 1 by Chemical Ribosomal Inactivation via p38 Mitogen-activated Protein Kinase (MAPK)-mediated Regulation: EVIDENCE FOR ENVIRONMENTAL HEMOCHROMATOSIS. Oh CK, Park SH, Kim J, Moon Y. J Biol Chem; 2016 Sep 16; 291(38):19858-72. PubMed ID: 27445333 [Abstract] [Full Text] [Related]
24. A novel mutation in ferroportin implicated in iron overload. Wallace DF, Dixon JL, Ramm GA, Anderson GJ, Powell LW, Subramaniam VN. J Hepatol; 2007 May 16; 46(5):921-6. PubMed ID: 17383046 [Abstract] [Full Text] [Related]
28. Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis. Valenti L, Pulixi EA, Arosio P, Cremonesi L, Biasiotto G, Dongiovanni P, Maggioni M, Fargion S, Fracanzani AL. Haematologica; 2007 Aug 16; 92(8):1037-42. PubMed ID: 17640859 [Abstract] [Full Text] [Related]
29. The molecular basis of iron overload disorders and iron-linked anemias. Kaplan J, Ward DM, De Domenico I. Int J Hematol; 2011 Jan 16; 93(1):14-20. PubMed ID: 21210258 [Abstract] [Full Text] [Related]
34. Autosomal dominant iron overload due to a novel mutation of ferroportin1 associated with parenchymal iron loading and cirrhosis. Wallace DF, Clark RM, Harley HA, Subramaniam VN. J Hepatol; 2004 Apr 16; 40(4):710-3. PubMed ID: 15030991 [Abstract] [Full Text] [Related]
36. Magnetic resonance imaging to identify classic and nonclassic forms of ferroportin disease. Pietrangelo A, Corradini E, Ferrara F, Vegetti A, De Jong G, Luca Abbati G, Paolo Arcuri P, Martinelli S, Cerofolini E. Blood Cells Mol Dis; 2006 Apr 16; 37(3):192-6. PubMed ID: 17052926 [Abstract] [Full Text] [Related]
37. Minimal effect of conditional ferroportin KO in the neural retina implicates ferrous iron in retinal iron overload and degeneration. Liu Y, Baumann B, Song Y, Zhang K, Sterling JK, Lakhal-Littleton S, Kozmik Z, Su G, Dunaief JL. Exp Eye Res; 2022 May 16; 218():108988. PubMed ID: 35202704 [Abstract] [Full Text] [Related]
38. Autosomal dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin 1 gene (SLC11A3). Devalia V, Carter K, Walker AP, Perkins SJ, Worwood M, May A, Dooley JS. Blood; 2002 Jul 15; 100(2):695-7. PubMed ID: 12091367 [Abstract] [Full Text] [Related]
39. Ferroportin disease mutations influence manganese accumulation and cytotoxicity. Choi EK, Nguyen TT, Iwase S, Seo YA. FASEB J; 2019 Feb 15; 33(2):2228-2240. PubMed ID: 30247984 [Abstract] [Full Text] [Related]